Inhibition_NN
of_IN
anti-CD3_JJ
monoclonal_JJ
antibody-induced_NN
T-cell_NN
proliferation_NN
by_IN
dexamethasone_NN
,_,
isoproterenol_NN
,_,
or_CC
prostaglandin_NN
E2_NN
either_CC
alone_RB
or_CC
in_IN
combination_NN
._.

1_LS
._.
The_DT
purpose_NN
of_IN
these_DT
studies_NNS
was_VBD
to_TO
investigate_VB
the_DT
modulation_NN
of_IN
the_DT
proliferation_NN
of_IN
human_JJ
T_NN
cells_NNS
obtained_VBN
from_IN
peripheral_JJ
blood_NN
by_IN
dexamethasone_NN
-LRB-_-LRB-
DEX_NN
-RRB-_-RRB-
,_,
isoproterenol_NN
-LRB-_-LRB-
ISO_NN
-RRB-_-RRB-
,_,
and_CC
prostaglandin_NN
E2_NN
-LRB-_-LRB-
PGE2_NN
-RRB-_-RRB-
._.

The_DT
former_JJ
two_CD
substances_NNS
interact_VBP
with_IN
T_NN
cells_NNS
via_IN
the_DT
glucocorticoid_NN
and_CC
beta-adrenergic_JJ
receptors_NNS
respectively_RB
._.

When_WRB
occupied_VBN
by_IN
their_PRP$
natural_JJ
ligands_NNS
,_,
glucocorticosteroids_NNS
and_CC
catecholamines_NNS
,_,
these_DT
receptors_NNS
have_VBP
a_DT
role_NN
in_IN
modulating_VBG
T-cell_NN
function_NN
during_IN
stress_NN
._.

During_IN
the_DT
inflammatory_JJ
response_NN
increased_VBN
levels_NNS
of_IN
PGE2_NN
bind_VBP
to_TO
their_PRP$
receptors_NNS
on_IN
T_NN
cells_NNS
and_CC
thus_RB
alter_VBP
responsiveness_NN
._.

Proliferation_NN
of_IN
T_NN
cells_NNS
was_VBD
induced_VBN
by_IN
immobilized_JJ
anti-CD3_JJ
monoclonal_JJ
antibody_NN
-LRB-_-LRB-
mAb_NN
-RRB-_-RRB-
in_IN
the_DT
presence_NN
or_CC
absence_NN
of_IN
an_DT
additional_JJ
costimulatory_JJ
signal_NN
delivered_VBN
by_IN
anti-CD28_JJ
mAb_NN
._.

2_LS
._.
Various_JJ
physiologic_JJ
concentrations_NNS
of_IN
DEX_NN
,_,
ISO_NN
,_,
or_CC
PGE2_NN
were_VBD
added_VBN
at_IN
the_DT
time_NN
of_IN
initiation_NN
of_IN
the_DT
cultures_NNS
and_CC
subsequent_JJ
proliferation_NN
of_IN
the_DT
unstimulated_JJ
T_NN
cells_NNS
was_VBD
determined_VBN
._.

The_DT
results_NNS
demonstrate_VBP
that_IN
physiologic_JJ
concentrations_NNS
of_IN
all_DT
three_CD
of_IN
these_DT
agents_NNS
inhibit_VBP
the_DT
anti-CD3_NN
mAb-induced_JJ
proliferation_NN
of_IN
T_NN
cells_NNS
._.

3_LS
._.
Although_IN
DEX_NN
and_CC
PGE2_NN
were_VBD
equipotent_JJ
in_IN
suppressing_VBG
T-cell_NN
proliferation_NN
,_,
ISO_NN
was_VBD
much_RB
less_RBR
effective_JJ
._.

4_LS
._.
Because_IN
concomitant_JJ
elevations_NNS
in_IN
the_DT
peripheral_JJ
levels_NNS
of_IN
these_DT
substances_NNS
may_MD
occur_VB
,_,
experiments_NNS
were_VBD
performed_VBN
to_TO
determine_VB
the_DT
T-cell_NN
inhibitory_JJ
effects_NNS
of_IN
DEX_NN
together_RB
with_IN
either_CC
PGE2_NN
or_CC
ISO_NN
._.

Synergistic_JJ
suppression_NN
of_IN
T-cell_NN
proliferation_NN
was_VBD
observed_VBN
when_WRB
various_JJ
concentrations_NNS
of_IN
DEX_NN
and_CC
PGE2_NN
,_,
but_CC
not_RB
DEX_NN
and_CC
ISO_NN
,_,
were_VBD
added_VBN
to_TO
cultures_NNS
._.

This_DT
synergistic_JJ
suppression_NN
could_MD
not_RB
be_VB
explained_VBN
by_IN
an_DT
increase_NN
in_IN
cAMP_NN
accumulation_NN
in_IN
T_NN
cells_NNS
stimulated_VBN
with_IN
DEX_NN
and_CC
PGE2_NN
._.

5_CD
._.
Finally_RB
,_,
the_DT
addition_NN
of_IN
anti-CD28_JJ
mAb_NN
to_TO
anti-CD3_NN
mAb-stimulated_JJ
T_NN
cells_NNS
overcame_VBD
much_JJ
of_IN
the_DT
suppression_NN
of_IN
proliferation_NN
induced_VBN
by_IN
PGE2_NN
or_CC
ISO_NN
but_CC
less_RBR
so_RB
than_IN
that_WDT
induced_VBN
by_IN
DEX_NN
._.

